The ASCA Affiliate Presentations are sponsored by Pacira BioSciences.
Presentations are launching July 9 and will be available through October 31.
Thursday, July 9
10:30 am–10:45 am
Efficient Pricing, Predictable Billing & Excellent Quality: How Procedure-Based Constructs Can Benefit Your ASC
Randy Grote, Sr. Marketing Manager, and Tricia Reilly, Marketing Manager, DePuy Synthes, a Johnson & Johnson Company
Learn about how your ASC can benefit from procedure-based construct pricing through the DePuy Synthes’ Pro-Pak® Program. DePuy Synthes Pro-Pak Constructs are specifically designed and exclusively available for independent Ambulatory Surgery Centers; bringing your ASC, efficient pricing, predictable billing and excellent product quality.
What is the Value of My ASC? Key Transaction Trends in 2020
David Lo, CFA, Manager, HealthCare Appraisers, Inc.
Understanding the factors impacting the fair market value of an ASC are key for anyone considering an ASC ownership interest transaction. Learn about the value drivers for ASCs and hear the latest transaction trends being observed in the market. If you are an administrator, physician or have any ownership interest in an ASC, this session is for you!
Getting the Most Money for Your ASC Through Technology
Robert Marinich, Vice President, HSTpathways
Learn how to improve your cashflow and earn a healthier bottom line by embracing today’s technology. This discussion will cover when, where and what technology to implement.
The 7 Things That Your ASC Needs To Update in Its Roadmap
Adam Steinhoff, CEO, Dedicated IT
Dedicated IT gets to help surgery centers across the nation build strategic IT business plans and roadmaps. During this talk, we will explain the fundamentals in what the purpose of a roadmap is, how to get started or update your current plan, the 7 things you should consider and update, and how to finalize it.
The Patient You Never See
Lucian Newman III, MD, FACS, CMIO, Chief Marking & Information Officer, Nuance
Catherine Gorman-Klug RN, Director of Quality Service Line, Nuance
The patient that you never see is the patient that you never have the opportunity to treat because they chose another provider based on publicly available quality scores. During the session learn where your data is published, the impact it has on reputation and reimbursement, and what you can do to achieve the best possible scores.
10:45 am–11:00 am
Keys to Successfully Selling an Interest in Your ASC or your ASC/MOB Real Estate
Jim Freund, Senior Partner ASC Inc.
At some point virtually every ASC owner will consider selling an interest in their business and/or their real estate. Learn about current opportunities and trends, the challenges and items to consider, the process and what goes into a successful transaction. If you are an administrator, a physician, or have an ownership interest in an ASC, this will help you better understand this once in a lifetime process and what to look for.
Proven Strategies to Super Charge your ASC Performance in the Era of COVID-19
Jeff Peters, CEO, Surgical Directions
Hear the CEO of Surgical Directions outline strategies for growing case volume and revenues. Case examples highlighting their time-tested methodologies designed to drive lasting change in operational, clinical and financial performance will be provided.
Building a Successful Total Joints Program in Your Surgery Center
Nader Samii, CEO, National Medical Billing Services
Scott McCaig, Director, Technology and Marketing, Outpatient Surgery Solutions, Smith+Nephew
National Medical and Smith+Nephew have partnered to deliver a comprehensive total joints program for surgery centers. Join us to learn about how this program aids ASCs in simultaneously achieving industry leading patient outcomes and financial success.
Total Joint Arthroplasty in the ASC: Clinical Outcomes in Medicare Patients
James Van Horne, MD, Orthopedic Surgeon, Paragon Orthopedic Center & TKA Outcomes
The steady growth of total joint arthroplasty (TJA) procedures in the outpatient setting continues. A review of Medicare and commercially insured patients undergoing TJA procedures to analyze the effect of opioid-minimization and enhanced recovery protocols highlights the implications of performing these procedures in an ambulatory setting. Learn about the published outcomes of two (2) peer-reviewed studies regarding TJA and the use of EXPAREL® (bupivacaine liposome injectable suspension).
11:00 am–11:15 am
Patient and Physician Engagement: Using Technology to Support Real-time Communications
Daren Smith, Director of ASC Solutions, Surgical Information Systems
Patient and physician engagement tools are a widely underappreciated resource in the ASC world, but these tools can have a positive impact on your facility’s operations. In this presentation, we explore how to use technology tools to improve communications with patients, physicians, and the surgeon’s office.
Regional Anesthesia and Outpatient Surgery
Gary S. Schwartz, MD, FASA, Anesthesiologist/Interventional Pain Management, AABP Pain Management, Maimonides Medical Center & Anesthesiology Associates of Boro Park LLP
The COVID-19 pandemic has resulted in a number of clinical and operational considerations in performing ambulatory procedures. Risk mitigation is central to recent changes in patient, clinical and facility management protocols. While necessary, these changes can limit an ASCs ability to achieve maximum patient throughput. The use of regional anesthesia with local analgesia in lieu of general anesthesia may assist with the need to limit the risk of aerosol generating procedures often associated with general anesthesia. Regional anesthesia with local analgesia can be an effective and efficient platform for ambulatory surgery. Learn about regional anesthesia with local analgesia and its use in the ASC.
Developing a Successful Employee Onboarding Program
Lauren Lockey, Recruitment and Development Manager, in2itive Business Solutions
As your ASC grows, so must your employee population. Join in as in2itive's very own recruitment and development manager outlines proven strategies for successfully onboarding new employees. She'll go beyond the first two weeks to ensure employees understand what's asked of them and how their supervisors can manage them to success.
Privilege your Providers and Credential your Ambulatory Surgical Centers easily with Credential Stream
Sarah Cassidy, Solution Executive, VerityStream
As payment reforms collide with consumer sentiment, and technology pushes outpatient care to new limits, outpatient surgeries in the United States are increasing. As demand spikes, ASCs are subject to a growing number of state, federal, and voluntary regulation and accreditation standards designed to ensure that patients receive safe, quality services. A scalable, automated provider management solution is essential to keep up. CredentialStream is that solution.
11:15 am–11:30 am
ASC Revenue Cycle: Key Performance Indicators to Monitor
Angela Mattioda, VP Quality, Surgical Notes
Find out how you can gain better control over your ASC's revenue cycle performance, spot problems hurting your bottom line and identify opportunities for improvement that can enhance profitability. Learn about monitoring key performance indicators and the top metrics worth tracking. Hear the target benchmarks, warning signs, common problems and solutions to help address your ASC’s obstacles to success.
EXPAREL® (bupivacaine liposome injectable suspension) Reimbursement in the ASC (C9290)
Anita Walsh, Executive Director of Marketing, Pacira BioSciences, Inc.
EXPAREL® (bupivacaine liposome injectable suspension) is a proven non-opioid long-lasting postsurgical pain management alternative. The CMS assigned HCPCS C9290 for EXPAREL® with a payment status of “allowed” effective January 1, 2019. Since then, Medicare has been paying separately for EXPAREL® and commercial payers across the country are increasingly following suit to separately reimburse EXPAREL®. Learn more how to code and bill C9290 for EXPAREL®.
Meet CMS Accreditation Requirements with a Robust Implant Database
Lindsay Frkovich Nelson, VP Sales & Marketing, OneSOURCE
Hear how having a surgical instrument, equipment and tissue and implant database is vital for patient and staff safety, in addition to assisting with compliance with accreditation requirements and CMS. In this demo from oneSOURCE.
Accelerating Your Revenue
Keith Gruebele, President of Business Development, BHG Patient Lending
Here's the opportunity for surgery centers: Embrace the financial component of healthcare as an integral part of the patient experience and overall success of your center. By shaping existing revenue cycle processes to become more patient-centric, centers can quickly accelerate revenue and simultaneously improve the experience for patients.
Friday, July 10,
10:45 am–11:00 am
Efficient Pricing, Predictable Billing & Excellent Quality: How Procedure-Based Constructs Can Benefit Your ASC
Randy Grote, Sr. Marketing Manager, and Tricia Reilly, Marketing Manager, DePuy Synthes, a Johnson & Johnson Company
Learn about how your ASC can benefit from procedure-based construct pricing through the DePuy Synthes’ Pro-Pak® Program. DePuy Synthes Pro-Pak Constructs are specifically designed and exclusively available for independent Ambulatory Surgery Centers; bringing your ASC, efficient pricing, predictable billing and excellent product quality.
What is the Value of My ASC? Key Transaction Trends in 2020
David Lo, CFA, Manager, HealthCare Appraisers, Inc.
Understanding the factors impacting the fair market value of an ASC are key for anyone considering an ASC ownership interest transaction. Learn about the value drivers for ASCs and hear the latest transaction trends being observed in the market. If you are an administrator, physician or have any ownership interest in an ASC, this session is for you!
Getting the Most Money for Your ASC Through Technology
Robert Marinich, Vice President, HSTpathways
Learn how to improve your cashflow and earn a healthier bottom line by embracing today’s technology. This discussion will cover when, where and what technology to implement.
The 7 Things That Your ASC Needs To Update in Its Roadmap
Adam Steinhoff, CEO, Dedicated IT
Dedicated IT gets to help surgery centers across the nation build strategic IT business plans and roadmaps. During this talk, we will explain the fundamentals in what the purpose of a roadmap is, how to get started or update your current plan, the 7 things you should consider and update, and how to finalize it.
The Patient You Never See
Lucian Newman III, MD, FACS, CMIO, Chief Marking & Information Officer, Nuance
Catherine Gorman-Klug RN, Director of Quality Service Line, Nuance
The patient that you never see is the patient that you never have the opportunity to treat because they chose another provider based on publicly available quality scores. During the session learn where your data is published, the impact it has on reputation and reimbursement, and what you can do to achieve the best possible scores.
11:00 am–11:15 am
Keys to Successfully Selling an Interest in Your ASC or your ASC/MOB Real Estate
Jim Freund, Senior Partner ASC Inc.
At some point virtually every ASC owner will consider selling an interest in their business and/or their real estate. Learn about current opportunities and trends, the challenges and items to consider, the process and what goes into a successful transaction. If you are an administrator, a physician, or have an ownership interest in an ASC, this will help you better understand this once in a lifetime process and what to look for.
Proven Strategies to Super Charge your ASC Performance in the Era of COVID-19
Jeff Peters, CEO, Surgical Directions
Hear the CEO of Surgical Directions outline strategies for growing case volume and revenues. Case examples highlighting their time-tested methodologies designed to drive lasting change in operational, clinical and financial performance will be provided.
Building a Successful Total Joints Program in Your Surgery Center
Nader Samii, CEO, National Medical Billing Services
Scott McCaig, Director, Technology and Marketing, Outpatient Surgery Solutions, Smith+Nephew
National Medical and Smith+Nephew have partnered to deliver a comprehensive total joints program for surgery centers. Join us to learn about how this program aids ASCs in simultaneously achieving industry leading patient outcomes and financial success.
Total Joint Arthroplasty in the ASC: Clinical Outcomes in Medicare Patients
James Van Horne, MD, Orthopedic Surgeon, Paragon Orthopedic Center & TKA Outcomes
The steady growth of total joint arthroplasty (TJA) procedures in the outpatient setting continues. A review of Medicare and commercially insured patients undergoing TJA procedures to analyze the effect of opioid-minimization and enhanced recovery protocols highlights the implications of performing these procedures in an ambulatory setting. Learn about the published outcomes of two (2) peer-reviewed studies regarding TJA and the use of EXPAREL® (bupivacaine liposome injectable suspension).
11:15 am–11:30 am
Patient and Physician Engagement: Using Technology to Support Real-time Communications
Daren Smith, Director of ASC Solutions, Surgical Information Systems
Patient and physician engagement tools are a widely underappreciated resource in the ASC world, but these tools can have a positive impact on your facility’s operations. In this presentation, we explore how to use technology tools to improve communications with patients, physicians, and the surgeon’s office.
Regional Anesthesia and Outpatient Surgery
Gary S. Schwartz, MD, FASA, Anesthesiologist/Interventional Pain Management, AABP Pain Management, Maimonides Medical Center & Anesthesiology Associates of Boro Park LLP
The COVID-19 pandemic has resulted in a number of clinical and operational considerations in performing ambulatory procedures. Risk mitigation is central to recent changes in patient, clinical and facility management protocols. While necessary, these changes can limit an ASCs ability to achieve maximum patient throughput. The use of regional anesthesia with local analgesia in lieu of general anesthesia may assist with the need to limit the risk of aerosol generating procedures often associated with general anesthesia. Regional anesthesia with local analgesia can be an effective and efficient platform for ambulatory surgery. Learn about regional anesthesia with local analgesia and its use in the ASC.
Developing a Successful Employee Onboarding Program
Lauren Lockey, Recruitment and Development Manager, in2itive Business Solutions
As your ASC grows, so must your employee population. Join in as in2itive's very own recruitment and development manager outlines proven strategies for successfully onboarding new employees. She'll go beyond the first two weeks to ensure employees understand what's asked of them and how their supervisors can manage them to success.
Privilege your Providers and Credential your Ambulatory Surgical Centers easily with Credential Stream
Sarah Cassidy, Solution Executive, VerityStream
As payment reforms collide with consumer sentiment, and technology pushes outpatient care to new limits, outpatient surgeries in the United States are increasing. As demand spikes, ASCs are subject to a growing number of state, federal, and voluntary regulation and accreditation standards designed to ensure that patients receive safe, quality services. A scalable, automated provider management solution is essential to keep up. CredentialStream is that solution.
11:30 am–11:45 am
ASC Revenue Cycle: Key Performance Indicators to Monitor
Angela Mattioda, VP Quality, Surgical Notes
Find out how you can gain better control over your ASC's revenue cycle performance, spot problems hurting your bottom line and identify opportunities for improvement that can enhance profitability. Learn about monitoring key performance indicators and the top metrics worth tracking. Hear the target benchmarks, warning signs, common problems and solutions to help address your ASC’s obstacles to success.
EXPAREL® (bupivacaine liposome injectable suspension) Reimbursement in the ASC (C9290)
Anita Walsh, Executive Director of Marketing, Pacira BioSciences, Inc.
EXPAREL® (bupivacaine liposome injectable suspension) is a proven non-opioid long-lasting postsurgical pain management alternative. The CMS assigned HCPCS C9290 for EXPAREL® with a payment status of “allowed” effective January 1, 2019. Since then, Medicare has been paying separately for EXPAREL® and commercial payers across the country are increasingly following suit to separately reimburse EXPAREL®. Learn more how to code and bill C9290 for EXPAREL®.
Meet CMS Accreditation Requirements with a Robust Implant Database
Lindsay Frkovich Nelson, VP Sales & Marketing, OneSOURCE
Hear how having a surgical instrument, equipment and tissue and implant database is vital for patient and staff safety, in addition to assisting with compliance with accreditation requirements and CMS. In this demo from oneSOURCE.
Accelerating Your Revenue
Keith Gruebele, President of Business Development, BHG Patient Lending
Here's the opportunity for surgery centers: Embrace the financial component of healthcare as an integral part of the patient experience and overall success of your center. By shaping existing revenue cycle processes to become more patient-centric, centers can quickly accelerate revenue and simultaneously improve the experience for patients.
The advice and opinions presented are those of the presenters and do not represent official Ambulatory Surgery Center Association policy or opinion.
This presentation may include opinions, advice, statements, materials, data, images, videos, documentation and other information (“Materials”) expressed or shared by presenters. The Materials are for informational purposes only, and the statements, views and opinions expressed at any presentation, or in any Materials, are those solely of the presenter and not of ASCA. Further, ASCA does not endorse or recommend any specific presenter, promoter, company or center, or any views mentioned at any conference or meeting, or in the Materials. Under no circumstances, will ASCA (or its directors, officers, employees or agents) be liable for the accuracy, quality or reliability of any of the presentations or Materials, or any defamatory, offensive or illegal conduct of presenters, including but not limited to intellectual property infringement, or any direct, indirect, incidental, special or consequential damages arising from any presentations, or Materials.